2 stories
AI briefings + tags; source links are the ground truth.
About
🇩🇪
Germany
FAZ
National & Local
Alzheimer: Are Alzheimer drugs really not useful?
Experts from the Joint Federal Committee of Germany find no additional benefit for the Alzheimer drug Lecanemab compared to existing therapies.
Feb 19 • 14:37 UTC
🇩🇪
Germany
SZ
National & Local
G-BA on Lecanemab: Setback for New Alzheimer Drug
Germany's G-BA has determined that Lecanemab offers no proven added benefit over existing Alzheimer's treatments, raising questions about its future use.
Feb 19 • 11:40 UTC